论文信息 - Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease - 字舞流文

Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease

H. Cramer | K. Rissler | C. Reuner | J. Geiger | N. Rösler

[1] B. Renaud,et al. Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease , 1988, Neuropeptides.

[2] H. Ørskov,et al. CEREBROSPINAL FLUID SOMATOSTATIN INVERSELY CORRELATED WITH DISEASE ACTIVITY IN MULTIPLE SCLEROSIS , 1983, The Lancet.

[3] A. P. Hansen,et al. The origin of cerebrospinal fluid somatostatin: hypothalamic or disperse central nervous system secretion? , 1981, Neuroendocrinology.

[4] A. P. Hansen,et al. Low somatostatin content in cerebrospinal fluid in multiple sclerosis , 1980, Acta neurologica Scandinavica.

[5] G. Ellison,et al. Criteria for the clinical diagnosis of multiple sclerosis , 1976, Neurology.